FDA Limits Use of Nizoral Antifungal Tablets Due to Risks for Liver Injury Infectious Disease Special Edition New labeling for Nizoral oral tablets states that the drug can cause liver injury that may potentially result in liver transplantation or death. A boxed warning includes a strong recommendation against the use of Nizoral tablets in patients with liver ... |
